抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產品編號 | 圖片 | 產品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
Olumacostat glasaretil，98% | C26H43NO7 | |||
|
|
|||||
|
Ro 41-1049 (hydrochloride)，99% | C12H13ClFN3OS | |||
|
|
|||||
|
Entacapone，99% | C14H15N3O5 | |||
|
|
|||||
|
AA26-9，99% | C7H10N4O | |||
|
|
|||||
|
GSK 2194069, (hFASN)抑制劑，≥97% | C25H24N4O3 | |||
|
|
|||||
|
SR1001，99% | C15H13F6N3O4S2 | |||
|
|
|||||
|
Mutant IDH1-IN-1，98% | C30H31FN4O2 | |||
|
|
|||||
|
AMG-3969，99% | C21H20F6N4O3S | |||
|
|
|||||
|
GNE-617，99% | C21H15F2N3O3S | |||
|
|
|||||
|
KML-29，98% | C24H21F6NO7 | |||
|
|
|||||
|
Ibiglustat，98% | C20H24FN3O2S | |||
|
|
|||||
|
IDO-IN-6，99% | C18H21FN2O2 | |||
|
|
|||||
|
IDO-IN-8，99% | C18H21FN2O2 | |||
|
|
|||||
|
Navoximod，98% | C18H21FN2O2 | |||
|
|
|||||
|
IDO-IN-5，99% | C18H21FN2O2 | |||
|
|
|||||
|
GSK256066 (2,2,2-trifluoroacetic acid)，98% | C29H27F3N4O7S | |||
|
|
|||||
|
CPDA，≥98% | C20H15ClF2N2O2 | |||
|
|
|||||
